Volume 15, Issue 56 (4-2021)
MLJ 2021, 15(56): 963-978 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Honari A, Mahdavi S M H, Nasiran Najafabadi D. The use of embryonic stem cells in the light of the international human rights system. MLJ 2021; 15 (56) :963-978
URL: http://ijmedicallaw.ir/article-1-1332-en.html
URL: http://ijmedicallaw.ir/article-1-1332-en.html
1- Najafabad Branch, Islamic Azad University, Najafabad, Iran
2- Department of Private Law, Najafabad Branch, Islamic Azad University, Najafabad, Iran
2- Department of Private Law, Najafabad Branch, Islamic Azad University, Najafabad, Iran
Abstract:
Background and Aim: There have been many advances in science and technology in recent years. One of the areas in which these advances have made great strides is the field of stem cells. In the process of using embryonic stem cells, it is possible for damaged organs to grow from stem cells. Embryonic stem cells are biologically productive, meaning they can grow in any human cell or organ. However, there are certain ethical challenges associated with this treatment.
Materials and Methods: This research is of theoretical type and the research method is descriptive-analytical and the method of data collection is library and has been done by referring to documents, books and articles.
Results: It seems that in the international human rights environment, the right to health and the commitment to ensure the application of all essential therapies can be exercised in the field of embryonic stem cell therapy. It should be noted that this treatment is in the research stage and except in special cases, there is no certainty in resorting to this treatment. According to the international human rights system, there is no obligation for governments to allocate funds for embryonic stem cell research.
Ethical considerations: In order to organize this research, while observing the authenticity of the texts, honesty and fidelity have been observed.
Conclusion: In connection with the use of embryonic cell therapies, we distinguish between two different assumptions. The first hypothesis is that patients with acute conditions (such as cancer patients) request embryonic stem cell therapy. Here it seems that by placing the patient's right to life at the top of the human rights hierarchy, it is possible to authorize the use of embryonic stem cell therapy. The second hypothesis is related to cases where patients are not in acute condition and are not at risk of death. Here, too, there is an important conflict between patients' right to health and the right to life of the embryo. Prioritizing patients' right to health in this assumption is hardly acceptable.
Cite this article as: Honari A, Mahdavi SM, Nasiran Najafabadi D. The use of embryonic stem cells in the light of the international human rights system. Medical Law Journal 2021; 15(56): e60.
Materials and Methods: This research is of theoretical type and the research method is descriptive-analytical and the method of data collection is library and has been done by referring to documents, books and articles.
Results: It seems that in the international human rights environment, the right to health and the commitment to ensure the application of all essential therapies can be exercised in the field of embryonic stem cell therapy. It should be noted that this treatment is in the research stage and except in special cases, there is no certainty in resorting to this treatment. According to the international human rights system, there is no obligation for governments to allocate funds for embryonic stem cell research.
Ethical considerations: In order to organize this research, while observing the authenticity of the texts, honesty and fidelity have been observed.
Conclusion: In connection with the use of embryonic cell therapies, we distinguish between two different assumptions. The first hypothesis is that patients with acute conditions (such as cancer patients) request embryonic stem cell therapy. Here it seems that by placing the patient's right to life at the top of the human rights hierarchy, it is possible to authorize the use of embryonic stem cell therapy. The second hypothesis is related to cases where patients are not in acute condition and are not at risk of death. Here, too, there is an important conflict between patients' right to health and the right to life of the embryo. Prioritizing patients' right to health in this assumption is hardly acceptable.
Cite this article as: Honari A, Mahdavi SM, Nasiran Najafabadi D. The use of embryonic stem cells in the light of the international human rights system. Medical Law Journal 2021; 15(56): e60.
Type of Study: Original Article |
Received: 2021/04/18 | Accepted: 2021/07/19
Received: 2021/04/18 | Accepted: 2021/07/19
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
